Melatonin Use Linked to Massively Increased Risk of Heart Failure

A recent study from the American Heart Association reveals a startling link between long-term melatonin use and a significantly higher risk of heart failure. Melatonin, a popular over-the-counter sleep aid, is often consumed in the form of gummies by those seeking better sleep. However, researchers have discovered that individuals who use melatonin supplements for a year or longer face a 90 percent increased likelihood of developing congestive heart failure within a five-year period.

It is important to note that this research is based on data from a large database of anonymous health records, rather than a clinical trial, which may limit its validity. The study analyzed two groups of chronic insomniacs: those who have taken melatonin for 12 months or more, and those who have not. Notably, the melatonin group saw a 4.6 percent rate of heart failure, compared to just 2.7 percent among the control group.

Furthermore, the researchers performed a secondary analysis which found that melatonin users were nearly three and a half times more likely to be hospitalized for heart failure than the control group. Hospitalization rates among melatonin users were 19.0 percent, compared to 6.6 percent among the control group. Dr. Ekenedilichukwu Nnadi, the study's lead author and chief resident in internal medicine at SUNY Brooklyn, expressed surprise at the consistent and significant rise in serious health outcomes even after accounting for various risk factors.

While more research is needed to confirm the study's findings, the results suggest that melatonin may not be as harmless as previously thought. Dr. Nnadi stated, "Melatonin supplements may not be as harmless as commonly assumed." This finding could potentially influence how doctors advise patients on sleep aids. The study highlights the need for further investigation into the long-term effects of melatonin use.